nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—DNMT1—adrenal cortex—bipolar disorder	0.00972	0.0393	CbGeAlD
Procainamide—CYP2D6—urine—bipolar disorder	0.0097	0.0393	CbGeAlD
Procainamide—SCN7A—thyroid gland—bipolar disorder	0.00881	0.0357	CbGeAlD
Procainamide—SCN11A—nervous system—bipolar disorder	0.00872	0.0353	CbGeAlD
Procainamide—BCHE—blood plasma—bipolar disorder	0.00764	0.031	CbGeAlD
Procainamide—DNMT1—thyroid gland—bipolar disorder	0.00677	0.0274	CbGeAlD
Procainamide—SCN11A—brain—bipolar disorder	0.00666	0.027	CbGeAlD
Procainamide—SCN8A—nervous system—bipolar disorder	0.0066	0.0267	CbGeAlD
Procainamide—Moclobemide—MAOA—bipolar disorder	0.0063	0.229	CrCbGaD
Procainamide—SCN8A—cerebellum—bipolar disorder	0.00622	0.0252	CbGeAlD
Procainamide—SCN4A—thyroid gland—bipolar disorder	0.00616	0.0249	CbGeAlD
Procainamide—Sunitinib—NTRK1—bipolar disorder	0.00609	0.221	CrCbGaD
Procainamide—DNMT1—nervous system—bipolar disorder	0.00569	0.0231	CbGeAlD
Procainamide—SCN7A—brain—bipolar disorder	0.00566	0.0229	CbGeAlD
Procainamide—ACHE—thyroid gland—bipolar disorder	0.0055	0.0223	CbGeAlD
Procainamide—DNMT1—cerebellum—bipolar disorder	0.00536	0.0217	CbGeAlD
Procainamide—SCN4A—nervous system—bipolar disorder	0.00518	0.021	CbGeAlD
Procainamide—CYP2D6—blood plasma—bipolar disorder	0.00506	0.0205	CbGeAlD
Procainamide—SCN8A—brain—bipolar disorder	0.00505	0.0204	CbGeAlD
Procainamide—SCN1A—nervous system—bipolar disorder	0.00499	0.0202	CbGeAlD
Procainamide—SCN3A—thyroid gland—bipolar disorder	0.00479	0.0194	CbGeAlD
Procainamide—SCN1A—cerebellum—bipolar disorder	0.0047	0.019	CbGeAlD
Procainamide—SCN2A—nervous system—bipolar disorder	0.00458	0.0186	CbGeAlD
Procainamide—Chloroprocaine—SLC6A3—bipolar disorder	0.0045	0.163	CrCbGaD
Procainamide—SCN9A—brain—bipolar disorder	0.00444	0.018	CbGeAlD
Procainamide—SCN10A—nervous system—bipolar disorder	0.00442	0.0179	CbGeAlD
Procainamide—ACHE—cerebellum—bipolar disorder	0.00435	0.0176	CbGeAlD
Procainamide—DNMT1—brain—bipolar disorder	0.00435	0.0176	CbGeAlD
Procainamide—SCN2A—cerebellum—bipolar disorder	0.00431	0.0175	CbGeAlD
Procainamide—Procaine—SLC6A3—bipolar disorder	0.00429	0.156	CrCbGaD
Procainamide—SLC22A4—thyroid gland—bipolar disorder	0.00419	0.017	CbGeAlD
Procainamide—SCN3A—nervous system—bipolar disorder	0.00403	0.0163	CbGeAlD
Procainamide—SCN5A—nervous system—bipolar disorder	0.00402	0.0163	CbGeAlD
Procainamide—SLC22A5—adrenal cortex—bipolar disorder	0.00398	0.0161	CbGeAlD
Procainamide—SCN4A—brain—bipolar disorder	0.00396	0.016	CbGeAlD
Procainamide—SCN1A—brain—bipolar disorder	0.00382	0.0155	CbGeAlD
Procainamide—SLC22A3—thyroid gland—bipolar disorder	0.00382	0.0155	CbGeAlD
Procainamide—SCN3A—cerebellum—bipolar disorder	0.00379	0.0153	CbGeAlD
Procainamide—Metoclopramide—DRD3—bipolar disorder	0.00376	0.137	CrCbGaD
Procainamide—ACHE—brain—bipolar disorder	0.00353	0.0143	CbGeAlD
Procainamide—SCN2A—brain—bipolar disorder	0.0035	0.0142	CbGeAlD
Procainamide—CHRM2—nervous system—bipolar disorder	0.00342	0.0138	CbGeAlD
Procainamide—SCN10A—brain—bipolar disorder	0.00338	0.0137	CbGeAlD
Procainamide—SLC22A1—nervous system—bipolar disorder	0.00336	0.0136	CbGeAlD
Procainamide—SLC22A4—cerebellum—bipolar disorder	0.00332	0.0134	CbGeAlD
Procainamide—SLC22A3—nervous system—bipolar disorder	0.00321	0.013	CbGeAlD
Procainamide—SCN3A—brain—bipolar disorder	0.00308	0.0125	CbGeAlD
Procainamide—SCN5A—brain—bipolar disorder	0.00307	0.0124	CbGeAlD
Procainamide—SLC22A5—thyroid gland—bipolar disorder	0.00277	0.0112	CbGeAlD
Procainamide—BCHE—thyroid gland—bipolar disorder	0.0027	0.0109	CbGeAlD
Procainamide—SLC22A4—brain—bipolar disorder	0.0027	0.0109	CbGeAlD
Procainamide—CHRM2—brain—bipolar disorder	0.00261	0.0106	CbGeAlD
Procainamide—Metoclopramide—DRD2—bipolar disorder	0.0026	0.0945	CrCbGaD
Procainamide—SLC22A1—brain—bipolar disorder	0.00257	0.0104	CbGeAlD
Procainamide—SLC22A3—brain—bipolar disorder	0.00245	0.00994	CbGeAlD
Procainamide—BCHE—nervous system—bipolar disorder	0.00227	0.00921	CbGeAlD
Procainamide—SLC22A5—cerebellum—bipolar disorder	0.0022	0.00889	CbGeAlD
Procainamide—BCHE—cerebellum—bipolar disorder	0.00214	0.00866	CbGeAlD
Procainamide—SLC22A5—brain—bipolar disorder	0.00178	0.00722	CbGeAlD
Procainamide—BCHE—brain—bipolar disorder	0.00174	0.00704	CbGeAlD
Procainamide—CYP2D6—nervous system—bipolar disorder	0.00151	0.0061	CbGeAlD
Procainamide—CYP2D6—cerebellum—bipolar disorder	0.00142	0.00574	CbGeAlD
Procainamide—CYP2D6—brain—bipolar disorder	0.00115	0.00466	CbGeAlD
Procainamide—SCN3A—Developmental Biology—GSK3B—bipolar disorder	0.000289	0.000398	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.000288	0.000397	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000288	0.000396	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—INS—bipolar disorder	0.000285	0.000392	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.000283	0.00039	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.000283	0.00039	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—TSHB—bipolar disorder	0.000279	0.000384	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000278	0.000383	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—GSK3B—bipolar disorder	0.000277	0.000382	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—GSK3B—bipolar disorder	0.000277	0.000382	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000277	0.000382	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NR1D1—bipolar disorder	0.000277	0.000381	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—ADM—bipolar disorder	0.000276	0.000381	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000276	0.00038	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—COMT—bipolar disorder	0.000276	0.00038	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000275	0.000379	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.000274	0.000377	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—MAOA—bipolar disorder	0.000274	0.000377	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—INS—bipolar disorder	0.000273	0.000377	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—INS—bipolar disorder	0.000273	0.000377	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—TSHB—bipolar disorder	0.000269	0.000371	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—TACR1—bipolar disorder	0.000269	0.000371	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—GSK3B—bipolar disorder	0.000267	0.000368	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—GSK3B—bipolar disorder	0.000267	0.000368	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.000266	0.000366	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NCAN—bipolar disorder	0.000265	0.000365	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—INS—bipolar disorder	0.000264	0.000363	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—INS—bipolar disorder	0.000264	0.000363	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—GSK3B—bipolar disorder	0.000263	0.000363	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000263	0.000363	CbGpPWpGaD
Procainamide—BCHE—Metabolism—IMPA1—bipolar disorder	0.000263	0.000362	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—SLC5A3—bipolar disorder	0.000259	0.000357	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—COMT—bipolar disorder	0.000257	0.000354	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000257	0.000354	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—MAOA—bipolar disorder	0.000255	0.000351	CbGpPWpGaD
Procainamide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000254	0.00035	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NDUFV2—bipolar disorder	0.00025	0.000345	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—TSHB—bipolar disorder	0.000249	0.000343	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.000248	0.000341	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000245	0.000338	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKR1C4—bipolar disorder	0.000242	0.000334	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—DGKH—bipolar disorder	0.000236	0.000326	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—IMPA1—bipolar disorder	0.000234	0.000323	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—NR3C1—bipolar disorder	0.00023	0.000317	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NDUFV2—bipolar disorder	0.000223	0.000308	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR1A—bipolar disorder	0.000223	0.000307	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—TAC1—bipolar disorder	0.00022	0.000303	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—IMPA1—bipolar disorder	0.000219	0.000301	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NR1D1—bipolar disorder	0.000218	0.0003	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKR1C4—bipolar disorder	0.000216	0.000298	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—DRD5—bipolar disorder	0.000216	0.000298	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR2C—bipolar disorder	0.000215	0.000297	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—DRD1—bipolar disorder	0.000215	0.000297	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—GSK3A—bipolar disorder	0.000215	0.000296	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—DGKH—bipolar disorder	0.000214	0.000296	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—RGS4—bipolar disorder	0.000212	0.000292	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—COMT—bipolar disorder	0.000209	0.000288	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—DRD3—bipolar disorder	0.000209	0.000287	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NCAN—bipolar disorder	0.000208	0.000287	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—MAOA—bipolar disorder	0.000207	0.000286	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	0.000206	0.000284	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SLC5A3—bipolar disorder	0.000204	0.000281	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.000202	0.000279	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—DRD4—bipolar disorder	0.000202	0.000279	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NDUFV2—bipolar disorder	0.000199	0.000275	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—TCF7L2—bipolar disorder	0.000197	0.000271	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—DRD5—bipolar disorder	0.000196	0.00027	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NR1D1—bipolar disorder	0.000194	0.000268	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKR1C4—bipolar disorder	0.000193	0.000266	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—RGS4—bipolar disorder	0.000192	0.000265	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—GSK3A—bipolar disorder	0.000192	0.000264	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—DRD2—bipolar disorder	0.000189	0.00026	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—GSK3B—bipolar disorder	0.000188	0.000259	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CLOCK—bipolar disorder	0.000187	0.000258	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NDUFV2—bipolar disorder	0.000186	0.000256	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NCAN—bipolar disorder	0.000186	0.000256	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—INS—bipolar disorder	0.000185	0.000256	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—TSHB—bipolar disorder	0.000183	0.000252	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—TPH2—bipolar disorder	0.000183	0.000252	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CACNB2—bipolar disorder	0.000183	0.000252	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SLC5A3—bipolar disorder	0.000182	0.000251	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKR1C4—bipolar disorder	0.00018	0.000248	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—DPYD—bipolar disorder	0.00018	0.000248	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000179	0.000247	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—IMPA2—bipolar disorder	0.000179	0.000246	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—TCF7L2—bipolar disorder	0.000175	0.000242	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000174	0.00024	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—POMC—bipolar disorder	0.000174	0.00024	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NR1D1—bipolar disorder	0.000173	0.000239	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000173	0.000239	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000173	0.000238	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CACNA1C—bipolar disorder	0.000167	0.00023	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NCAN—bipolar disorder	0.000166	0.000229	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TRPC3—bipolar disorder	0.000164	0.000226	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3C2A—bipolar disorder	0.000163	0.000224	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SLC5A3—bipolar disorder	0.000163	0.000224	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000162	0.000224	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NR1D1—bipolar disorder	0.000162	0.000223	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000161	0.000222	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ADM—bipolar disorder	0.000156	0.000215	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NCAN—bipolar disorder	0.000155	0.000213	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PDE4B—bipolar disorder	0.000152	0.00021	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TSHB—bipolar disorder	0.000152	0.00021	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TACR1—bipolar disorder	0.000152	0.00021	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SLC5A3—bipolar disorder	0.000151	0.000209	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TRPC3—bipolar disorder	0.000149	0.000205	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CLOCK—bipolar disorder	0.000147	0.000203	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—SNAP25—bipolar disorder	0.000146	0.000201	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TPH2—bipolar disorder	0.000144	0.000198	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TSHB—bipolar disorder	0.000144	0.000198	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CACNB2—bipolar disorder	0.000144	0.000198	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADM—bipolar disorder	0.000142	0.000195	CbGpPWpGaD
Procainamide—ACHE—Metabolism—DPYD—bipolar disorder	0.000141	0.000195	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.000139	0.000191	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PDE4B—bipolar disorder	0.000138	0.00019	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TACR1—bipolar disorder	0.000138	0.00019	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TSHB—bipolar disorder	0.000138	0.00019	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKR1C4—bipolar disorder	0.000138	0.00019	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—POMC—bipolar disorder	0.000135	0.000186	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR2A—bipolar disorder	0.000132	0.000182	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CLOCK—bipolar disorder	0.000132	0.000181	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CACNA1C—bipolar disorder	0.000131	0.000181	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ADCY2—bipolar disorder	0.000129	0.000178	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CACNB2—bipolar disorder	0.000128	0.000177	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TSHB—bipolar disorder	0.000128	0.000177	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TPH2—bipolar disorder	0.000128	0.000177	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3C2A—bipolar disorder	0.000128	0.000177	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DGKH—bipolar disorder	0.000127	0.000175	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000126	0.000174	CbGpPWpGaD
Procainamide—BCHE—Metabolism—DPYD—bipolar disorder	0.000126	0.000174	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR1A—bipolar disorder	0.000126	0.000174	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TAC1—bipolar disorder	0.000124	0.000171	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2C—bipolar disorder	0.000122	0.000168	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—DRD1—bipolar disorder	0.000122	0.000168	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—IMPA1—bipolar disorder	0.000121	0.000166	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—DRD3—bipolar disorder	0.000118	0.000162	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CLOCK—bipolar disorder	0.000118	0.000162	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CACNA1C—bipolar disorder	0.000117	0.000162	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DRD5—bipolar disorder	0.000116	0.00016	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SNAP25—bipolar disorder	0.000115	0.000158	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TSHB—bipolar disorder	0.000115	0.000158	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TPH2—bipolar disorder	0.000115	0.000158	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CACNB2—bipolar disorder	0.000115	0.000158	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR1A—bipolar disorder	0.000114	0.000158	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—DRD4—bipolar disorder	0.000114	0.000158	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3C2A—bipolar disorder	0.000114	0.000158	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RGS4—bipolar disorder	0.000114	0.000157	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000113	0.000155	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TAC1—bipolar disorder	0.000113	0.000155	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—DPYD—bipolar disorder	0.000113	0.000155	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—COMT—bipolar disorder	0.000111	0.000152	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—DRD1—bipolar disorder	0.00011	0.000152	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2C—bipolar disorder	0.00011	0.000152	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MAOA—bipolar disorder	0.00011	0.000151	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CLOCK—bipolar disorder	0.00011	0.000151	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—POMC—bipolar disorder	0.000109	0.000151	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—INS—bipolar disorder	0.000109	0.00015	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ADCY2—bipolar disorder	0.000108	0.000148	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—DRD3—bipolar disorder	0.000107	0.000147	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TPH2—bipolar disorder	0.000107	0.000147	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TSHB—bipolar disorder	0.000107	0.000147	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CACNB2—bipolar disorder	0.000107	0.000147	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—DRD2—bipolar disorder	0.000107	0.000147	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—POMC—bipolar disorder	0.000105	0.000145	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—DPYD—bipolar disorder	0.000105	0.000145	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CACNA1C—bipolar disorder	0.000105	0.000144	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—DRD4—bipolar disorder	0.000104	0.000143	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NDUFV2—bipolar disorder	0.000103	0.000141	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SNAP25—bipolar disorder	0.000103	0.000141	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3C2A—bipolar disorder	0.000102	0.000141	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ADCY2—bipolar disorder	0.000102	0.00014	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKR1C4—bipolar disorder	9.94e-05	0.000137	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADCY2—bipolar disorder	9.78e-05	0.000135	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CACNA1C—bipolar disorder	9.76e-05	0.000135	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—POMC—bipolar disorder	9.74e-05	0.000134	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—INS—bipolar disorder	9.69e-05	0.000134	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—DRD2—bipolar disorder	9.68e-05	0.000133	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3C2A—bipolar disorder	9.51e-05	0.000131	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SNAP25—bipolar disorder	9.16e-05	0.000126	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ADCY2—bipolar disorder	9.07e-05	0.000125	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MTHFR—bipolar disorder	8.94e-05	0.000123	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NR1D1—bipolar disorder	8.93e-05	0.000123	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TRPC3—bipolar disorder	8.78e-05	0.000121	CbGpPWpGaD
Procainamide—ACHE—Metabolism—COMT—bipolar disorder	8.71e-05	0.00012	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MAOA—bipolar disorder	8.65e-05	0.000119	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NCAN—bipolar disorder	8.54e-05	0.000118	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SNAP25—bipolar disorder	8.53e-05	0.000118	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADM—bipolar disorder	8.38e-05	0.000115	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC5A3—bipolar disorder	8.37e-05	0.000115	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TSHB—bipolar disorder	8.16e-05	0.000113	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDE4B—bipolar disorder	8.16e-05	0.000113	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TACR1—bipolar disorder	8.16e-05	0.000113	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADCY2—bipolar disorder	8.1e-05	0.000112	CbGpPWpGaD
Procainamide—BCHE—Metabolism—COMT—bipolar disorder	7.77e-05	0.000107	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MAOA—bipolar disorder	7.71e-05	0.000106	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADCY2—bipolar disorder	7.55e-05	0.000104	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2A—bipolar disorder	7.46e-05	0.000103	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—POMC—bipolar disorder	7.15e-05	9.86e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—INS—bipolar disorder	7.11e-05	9.8e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—bipolar disorder	7.04e-05	9.7e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—COMT—bipolar disorder	6.94e-05	9.56e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MAOA—bipolar disorder	6.89e-05	9.5e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2A—bipolar disorder	6.78e-05	9.34e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR1A—bipolar disorder	6.76e-05	9.31e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TAC1—bipolar disorder	6.66e-05	9.17e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2C—bipolar disorder	6.53e-05	9e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DRD1—bipolar disorder	6.53e-05	9e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—COMT—bipolar disorder	6.47e-05	8.91e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MAOA—bipolar disorder	6.42e-05	8.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NTRK2—bipolar disorder	6.35e-05	8.75e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DRD3—bipolar disorder	6.32e-05	8.71e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GSK3A—bipolar disorder	6.29e-05	8.67e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—bipolar disorder	6.28e-05	8.66e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DRD4—bipolar disorder	6.14e-05	8.46e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CLOCK—bipolar disorder	6.05e-05	8.34e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	5.96e-05	8.22e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TPH2—bipolar disorder	5.9e-05	8.13e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TSHB—bipolar disorder	5.9e-05	8.13e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CACNB2—bipolar disorder	5.9e-05	8.13e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—DPYD—bipolar disorder	5.8e-05	7.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	5.78e-05	7.96e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	5.76e-05	7.93e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DRD2—bipolar disorder	5.72e-05	7.88e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POMC—bipolar disorder	5.63e-05	7.76e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—bipolar disorder	5.61e-05	7.73e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—INS—bipolar disorder	5.6e-05	7.72e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—POMC—bipolar disorder	5.41e-05	7.46e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CACNA1C—bipolar disorder	5.39e-05	7.43e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	5.25e-05	7.24e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—bipolar disorder	5.23e-05	7.2e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	5.18e-05	7.13e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—S100B—bipolar disorder	5.03e-05	6.93e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POMC—bipolar disorder	5.02e-05	6.92e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—INS—bipolar disorder	4.99e-05	6.88e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SNAP25—bipolar disorder	4.71e-05	6.5e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POMC—bipolar disorder	4.49e-05	6.18e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—INS—bipolar disorder	4.46e-05	6.15e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NRG1—bipolar disorder	4.44e-05	6.12e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POMC—bipolar disorder	4.18e-05	5.76e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADCY2—bipolar disorder	4.17e-05	5.75e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—INS—bipolar disorder	4.16e-05	5.73e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	4e-05	5.52e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—COMT—bipolar disorder	3.57e-05	4.92e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MAOA—bipolar disorder	3.55e-05	4.89e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	3.22e-05	4.44e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—POMC—bipolar disorder	3.2e-05	4.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INS—bipolar disorder	3.18e-05	4.38e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—bipolar disorder	2.89e-05	3.98e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POMC—bipolar disorder	2.31e-05	3.18e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—INS—bipolar disorder	2.3e-05	3.16e-05	CbGpPWpGaD
